medmix AG (MEDX) - Cash Flow Conversion Efficiency
Based on the latest financial reports, medmix AG (MEDX) has a cash flow conversion efficiency ratio of 0.086x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CHF37.40 Million ≈ $47.28 Million USD) by net assets (CHF432.80 Million ≈ $547.18 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see MEDX market cap overview for the company's overall valuation and market capitalisation.
medmix AG - Cash Flow Conversion Efficiency Trend (2018–2025)
This chart illustrates how medmix AG's cash flow conversion efficiency has evolved over time, based on yearly financial data.
medmix AG Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of medmix AG ranked by their cash flow conversion efficiency. Explore earnings quality score of medmix AG to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Archer Ltd.
LSE:0RBA
|
0.017x |
|
Beijing Infosec Technologies Co. Ltd. A
SHG:688201
|
N/A |
|
GuangZhou Wahlap Technology Corporation Limited
SHE:301011
|
0.043x |
|
INPAQ Technology Co Ltd
TWO:6284
|
0.036x |
|
Third Point Investors Limited
LSE:TPOU
|
-0.004x |
|
Orthofix Medical Inc
NASDAQ:OFIX
|
-0.040x |
|
Hanwha Galleria Corp.
KO:452260
|
N/A |
|
Camping World Holdings Inc
NYSE:CWH
|
0.290x |
Annual Cash Flow Conversion Efficiency for medmix AG (2018–2025)
The table below shows the annual cash flow conversion efficiency of medmix AG from 2018 to 2025. View MEDX stock price and chart for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CHF432.80 Million ≈ $547.18 Million |
CHF67.80 Million ≈ $85.72 Million |
0.157x | -19.19% |
| 2024-12-31 | CHF446.70 Million ≈ $564.75 Million |
CHF86.60 Million ≈ $109.49 Million |
0.194x | +63.94% |
| 2023-12-31 | CHF474.40 Million ≈ $599.77 Million |
CHF56.10 Million ≈ $70.93 Million |
0.118x | +25.41% |
| 2022-12-31 | CHF504.80 Million ≈ $638.20 Million |
CHF47.60 Million ≈ $60.18 Million |
0.094x | -42.33% |
| 2021-12-31 | CHF533.90 Million ≈ $674.99 Million |
CHF87.30 Million ≈ $110.37 Million |
0.164x | +7.74% |
| 2020-12-31 | CHF333.40 Million ≈ $421.51 Million |
CHF50.60 Million ≈ $63.97 Million |
0.152x | -49.73% |
| 2019-12-31 | CHF295.10 Million ≈ $373.09 Million |
CHF89.10 Million ≈ $112.65 Million |
0.302x | +8.88% |
| 2018-12-31 | CHF339.70 Million ≈ $429.47 Million |
CHF94.20 Million ≈ $119.09 Million |
0.277x | -- |
About medmix AG
medmix AG designs, produces, and sells high-precision devices and services in Switzerland and internationally. It operates through the Healthcare, and Consumer and Industrial segments. The company offers dispensers, cartridges, mixers, tips, syringes, pen, and auto injectors for delivery of dental materials; delivery devices and mixing for bone repair and tissue treatment, which are used for pros… Read more